Spire Healthcare Group (LON:SPI) Stock Price Passes Above 50 Day Moving Average - Should You Sell?

Key Points

• Spire Healthcare Group's stock price has recently surpassed its 50-day moving average, trading at GBX 242 ($3.22).
• Wall Street analysts generally maintain a positive outlook, with a consensus Buy rating and a target price of approximately GBX 294.33.
• The company's latest quarterly earnings report showed an EPS of GBX 4.10, with forecasts predicting an EPS of around 15.66 for the current fiscal year.

Spire Healthcare Group plc (LON:SPI - Get Free Report)'s stock price passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of GBX 229.41 ($3.05) and traded as high as GBX 242 ($3.22). Spire Healthcare Group shares last traded at GBX 242 ($3.22), with a volume of 514,380 shares traded.

Wall Street Analysts Forecast Growth

SPI has been the topic of several research reports. JPMorgan Chase & Co. dropped their target price on Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating on the stock in a research report on Tuesday, August 5th. Berenberg Bank reissued a "buy" rating and issued a GBX 280 target price on shares of Spire Healthcare Group in a research report on Thursday, July 31st. Three analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Spire Healthcare Group presently has an average rating of "Buy" and a consensus target price of GBX 294.33.

Spire Healthcare Group Price Performance

The firm has a 50 day moving average price of GBX 229.41 and a 200 day moving average price of GBX 214.23. The company has a quick ratio of 0.74, a current ratio of 0.70 and a debt-to-equity ratio of 62.25. The stock has a market cap of £973.74 million, a P/E ratio of 52.61, a P/E/G ratio of 1.06 and a beta of 0.96.

Spire Healthcare Group (LON:SPI - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The company reported GBX 4.10 EPS for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. On average, analysts forecast that Spire Healthcare Group plc will post 15.6634747 EPS for the current fiscal year.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.